• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Happiness Development Granted Extension to Meet Nasdaq Minimum Bid Price Requirement

    5/16/22 8:00:00 AM ET
    $HAPP
    Medicinal Chemicals and Botanical Products
    Health Care
    Get the next $HAPP alert in real time by email

    NANPING, China, May 16, 2022 /PRNewswire/ -- Happiness Development Group Limited ("HAPP" or the "Company"), (NASDAQ:HAPP) an emerging and diversified company engaging in the business of production and sale of nutraceutical and dietary supplements, of e-commerce and providing marketing solutions, and of the sales of automobile, today announced that on May 11, 2022, the Company received a written notification from the Nasdaq's Listing Qualifications Department, granting the Company another 180 calendar days extension, or until November 7, 2022, to regain compliance with Nasdaq's minimum bid price requirement.

    The Company can cure this deficiency if the closing bid price of its Class A ordinary shares is $1.00 per share or higher for at least 10 consecutive business days during this second compliance period. The Company intends to regain compliance with the minimum bid price requirement on or before November 7, 2022 and is considering all available options, including a reverse stock split if necessary. During this time, the Company's Class A ordinary shares will continue to be listed and traded on the Nasdaq Capital Market, and this notice will have no effect on the operations of the Company's business.

    About Happiness Development Group Limited

    Headquartered in Nanping, China, Happiness Development Group Limited currently has three business lines: nutraceutical and dietary supplements, e-commerce and marketing solutions, and automobile sales. The nutrition and dietary supplements business is focusing on the research, development, manufacture and marketing of various products made from Chinese herbal extracts and other ingredients. Our e-commerce business focuses on offering e-commerce solutions, including advertising and information technology services to small and medium-sized enterprises in China. We also run our online stores which carries our products of dietary supplements and other selected products sourced from the small and medium-sized enterprises in China. Our mission for the e-commerce business is to enable small and medium-sized enterprises to fully leverage the power of e-commerce to grow rapidly. Our automobile sales adopts B2B business model and is committed to optimizing the automobile supply chain by offering standardized vehicle sources on our automobile online sales platform and providing secure transaction environment,  automobile procurement and financial services for automobile manufacturers. For more information, please visit: www.happ.org.cn

    Forward-Looking Statements

    This press release contains forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events or performance, and underlying assumptions and other statements that are other than statements of historical facts. When the Company uses words such as "may, "will, "intend," "should," "believe," "expect," "anticipate," "project," "estimate" or similar expressions that do not relate solely to historical matters, it is making forward-looking statements. Forward-looking statements are not guarantees of future performance and involve risks and uncertainties that may cause the actual results to differ materially from the Company's expectations discussed in the forward-looking statements. These statements are subject to uncertainties and risks including, but not limited to, the following: the occurrence of any event, change or other circumstances that could give rise to the terms of the Agreement not hereafter being memorialized in a definitive agreement; the outcome of any legal proceedings that have been, or will be, instituted against the Company or other parties to the Agreement following announcement of the Agreement and transactions contemplated therein; the inability to complete the transactions contemplated by the Agreement due to unsatisfied closing conditions; risks that the proposed transaction disrupts current plans and operations as a result of the announcement of the Agreement and consummation of the transaction described therein; costs related to the proposed transactions contemplated by the Agreement; changes in applicable laws or regulations; and other risks and uncertainties described herein, as well as those risks and uncertainties contained in reports filed by the Company with the Securities and Exchange Commission.  For these reasons, among others, investors are cautioned not to place undue reliance upon any forward-looking statements in this press release. Additional factors are discussed in the Company's filings with the U.S. Securities and Exchange Commission, which are available for review at www.sec.gov. The Company undertakes no obligation to publicly revise these forward-looking statements to reflect events or circumstances that arise after the date hereof.

    Cision View original content:https://www.prnewswire.com/news-releases/happiness-development-granted-extension-to-meet-nasdaq-minimum-bid-price-requirement-301547648.html

    SOURCE Happiness Development Group Limited

    Get the next $HAPP alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $HAPP

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $HAPP
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Happiness Development Group Limited Announces Name Change to Paranovus Entertainment Technology Ltd.

    NANPING, China, March 13, 2023 /PRNewswire/ -- Happiness Development Group Limited ("HAPP" or the "Company"), (NASDAQ:HAPP) is pleased to announce that effective on March 14, 2023, the Company will change its name to "Paranovus Entertainment Technology Ltd.", which better reflects the Company's strategic business expansion and less limiting than the current name. In connection with the name change, the trading symbol of the Class A ordinary shares will be changed to "PAVS" on the Nasdaq Stock Market, effective on March 14, 2023. Xuezhu Wang, the CEO and the Chairman of the Board of the Company, commented, "This new name will reflect the company's evolving focus and strategy. The company is p

    3/13/23 9:10:00 AM ET
    $HAPP
    Medicinal Chemicals and Botanical Products
    Health Care

    Happiness Development Group Limited Regains Compliance with Nasdaq Minimum Bid Price Requirement

    NANPING, China, Oct. 27, 2022 /PRNewswire/ -- Happiness Development Group Limited ("HAPP" or the "Company"), (NASDAQ:HAPP) announced today that on October 25, 2022, the Company received a notification letter from the Nasdaq Listing Qualifications Staff of The NASDAQ Stock Market LLC ("Nasdaq") notifying the Company that it has regained compliance with the Nasdaq's minimum bid price requirement and the matter is closed. On November 11, 2021, the Company was first notified by Nasdaq its failure to maintain a minimum bid price of $1.00 per share for 30 consecutive business days under Nasdaq Listing Rules 5550(a)(2) and 5810(c)(3)(A), and was given its first 180-day extension, or until May 10, 2

    10/27/22 8:00:00 AM ET
    $HAPP
    Medicinal Chemicals and Botanical Products
    Health Care

    Happiness Development Group Limited Announces 1 for 20 Reverse Share Split

    NANPING, China, Oct. 10, 2022 /PRNewswire/ -- Happiness Development Group Limited ("HAPP" or the "Company"), (NASDAQ:HAPP) an emerging and diversified company engaging in the business of production and sale of nutraceutical and dietary supplements, providing e-commerce sales and marketing solutions, and the sales of automobile today announced that an 1 for 20 reverse split of its ordinary shares, par value $0.0005 each, was approved by the Company's shareholders on October 7, 2022 and became effective on October 10, 2022. In connection with the reverse share split, the Company's shareholders will receive one new ordinary share of the Company for every twenty shares they hold. The Company's o

    10/10/22 8:00:00 AM ET
    $HAPP
    Medicinal Chemicals and Botanical Products
    Health Care

    $HAPP
    SEC Filings

    View All

    SEC Form 6-K filed by Happiness Development Group Limited

    6-K - Paranovus Entertainment Technology Ltd. (0001751876) (Filer)

    1/23/24 4:15:34 PM ET
    $HAPP
    Medicinal Chemicals and Botanical Products
    Health Care

    SEC Form 6-K filed by Happiness Development Group Limited

    6-K - Paranovus Entertainment Technology Ltd. (0001751876) (Filer)

    1/12/24 4:15:56 PM ET
    $HAPP
    Medicinal Chemicals and Botanical Products
    Health Care

    SEC Form 6-K filed by Happiness Development Group Limited

    6-K - Paranovus Entertainment Technology Ltd. (0001751876) (Filer)

    12/5/23 5:25:25 PM ET
    $HAPP
    Medicinal Chemicals and Botanical Products
    Health Care

    $HAPP
    Financials

    Live finance-specific insights

    View All

    Happiness Development Announces Financial Results for the Six Months Ended September 30, 2021

    NANPING, China, Jan. 6, 2022 /PRNewswire/ -- Happiness Development Group Limited ("HAPP" or the "Company"), (NASDAQ:HAPP) a China-based company engaging in the business of production of nutraceutical and dietary supplements, providing e-commerce sales and e-commerce marketing solutions, and the sales of automobile today announced its unaudited financial results for the six months ended September 30, 2021. Financial Highlights for the six months ended September 30, 2021: Revenues increased by $25.01 million or 114.3%, to $46.88 million for the six months ended September 30, 2021 from $21.88 million for the six months ended September 30, 2020, mainly due to the start-up of new goods or service

    1/6/22 8:00:00 AM ET
    $HAPP
    Medicinal Chemicals and Botanical Products
    Health Care

    Happiness Biotech Acquires Majority Ownership in Fujian Shennong

    NANPING, China, Oct. 25, 2021 /PRNewswire/ -- Happiness Biotech Group Limited ((the ", Company", NASDAQ:HAPP), a China-based company engaging in the business of production of nutraceutical and dietary supplements, providing e-commerce solutions, and the sales of automobile, today announced that it and its wholly owned-subsidiary, Fujian Happiness Biotech Co., Limited ("Happiness Fujian") have signed a share transfer agreement (the "Agreement") to acquire 70% of the equity interest in Fujian Shennong Jiagu Development Co., Ltd. ("Fujian Shennong") to further strengthen the Company's industrial integration. Fujian Shennong is a company with a solid customer's base, focusing on the trading of a

    10/25/21 8:00:00 AM ET
    $HAPP
    Medicinal Chemicals and Botanical Products
    Health Care

    Happiness Biotech Announces Financial Results for the Six Months Ended September 30, 2020 and Provides Guidance For the Whole Fiscal Year Ending March 31, 2021

    NANPING, China, Jan. 22, 2021 /PRNewswire/ -- Happiness Biotech Group Limited (the "Company" orNasdaq: HAPP), an innovative China-based nutraceutical and dietary supplements producer, today announced its unaudited financial results for the six months ended September 30, 2020 and provided the guidance for the whole fiscal year ending March 31, 2021. Financial Highlights for the six months ended September 30, 2020: Revenues decreased by $9.48 million or 30.2%, to $21.88 million for the six months ended September 30, 2020 from $31.36 million for the six months ended September 30, 2019, mainly due to the declining retail market affected by the COVID-19. Operating income was $3.69 million fo

    1/22/21 8:00:00 AM ET
    $HAPP
    Medicinal Chemicals and Botanical Products
    Health Care

    $HAPP
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Happiness Development Group Limited

    SC 13G - Paranovus Entertainment Technology Ltd. (0001751876) (Subject)

    10/12/23 5:48:39 PM ET
    $HAPP
    Medicinal Chemicals and Botanical Products
    Health Care

    SEC Form SC 13G filed by Happiness Development Group Limited

    SC 13G - Paranovus Entertainment Technology Ltd. (0001751876) (Subject)

    10/12/23 5:52:26 PM ET
    $HAPP
    Medicinal Chemicals and Botanical Products
    Health Care

    SEC Form SC 13D/A filed by Happiness Development Group Limited (Amendment)

    SC 13D/A - Paranovus Entertainment Technology Ltd. (0001751876) (Subject)

    7/28/23 4:15:28 PM ET
    $HAPP
    Medicinal Chemicals and Botanical Products
    Health Care